# Anlon Healthcare Limited (AHCL)

> AHCL closed at ₹25.89 on 30 Oct 2026, trailing P/E 49.5, market cap ₹1,376 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Anlon Healthcare Limited (NSE: AHCL) closed at ₹25.89 on 30 Oct 2026, +103.9% over one year, against a 52-week range of ₹10.37 – ₹37.24.

In the quarter ended 30 Sept 2026 (consolidated, filed 29 Oct 2026) it reported revenue of ₹106 cr and net profit of ₹13 cr, a 12.7% net margin; revenue grew 102.3% and profit grew 88.6% year on year.

On four consecutive filed quarters its trailing P/E is 49.5.

From the balance sheet dated 30 Sept 2026: return on equity 20.8%, ROCE 31.7%, debt-to-equity 0.28, Piotroski F-score 5 of 9.

Against 66 Healthcare peers on NSE: Net margin higher than 48% of 64 sector peers; PBT margin higher than 67% of 64 sector peers; ROE higher than 77% of 64 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹25.89 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -9.6% / +63.1% / +103.9% |
| 52-week low – high | ₹10.37 – ₹37.24 |
| Market capitalisation | ₹1,376 cr |
| Trailing P/E | 49.5 |
| Price / book | 6.18 |
| EV / EBITDA | 29.5 |
| Earnings yield | 2.0% |
| TTM EPS | ₹0.52 |
| TTM net profit | ₹28 cr |
| Quarter revenue | ₹106 cr |
| Quarter net profit | ₹13 cr |
| Net margin | 12.7% |
| Revenue growth (YoY) | +102.3% |
| Profit growth (YoY) | +88.6% |
| Return on equity | 20.8% |
| ROCE | 31.7% |
| Debt / equity | 0.28 |
| Current ratio | 2.54 |
| Free cash flow | ₹-36 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹14.5 cr |

## Questions

### What is the P/E ratio of Anlon Healthcare Limited?

Anlon Healthcare Limited's trailing P/E is 49.5, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026.

### What were Anlon Healthcare Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Anlon Healthcare Limited reported revenue of ₹106 cr and net profit of ₹13 cr (consolidated), filed with the exchange on 29 Oct 2026.

### What is Anlon Healthcare Limited's ROE?

Return on equity is 20.8% based on the balance sheet dated 30 Sept 2026.

### Does Anlon Healthcare Limited have debt?

Debt-to-equity is 0.28 on the balance sheet dated 30 Sept 2026.

### What is AHCL's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, AHCL traded between ₹10.37 and ₹37.24.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/AHCL

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._